Stonepine Capital Management, LLC Contrafect Corp Transaction History

Stonepine Capital Management, LLC

  • $158 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$2.47 - $4.14 $85,000 - $142,469
-34,413 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$3.19 - $4.43 $104,616 - $145,281
-32,795 Reduced 48.8%
34,413 $139,000
Q2 2021

Aug 16, 2021
SELL
$3.58 - $4.9 $722,776 - $989,275
-201,893 Reduced 75.02%
67,208 $296,000
Q1 2021

May 14, 2021
BUY
$4.46 - $6.68 $1.2 Million - $1.8 Million
269,101 New
269,101 $1.29 Million

Others Institutions Holding CFRX

# of Institutions
2
Shares Held
49.2K
Call Options Held
0
Put Options Held
0
View Full List

About CONTRAFECT Corp

CFRX Quotes by TradingView
  • Ticker CFRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,332,700
  • Market Cap $1.18M
  • Description
  • ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus...
More about CFRX
Track This Portfolio

Track Stonepine Capital Management, LLC Portfolio

Follow Stonepine Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonepine Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email